NIH grant rejections have reportedly more than doubled. This increase has sparked concern over the future of cancer research in the United States, with some expressing worry about the impact on breakthroughs in areas such as breast cancer. However, the exact nature and extent of the issue are unclear, with reports touching on various aspects of health research and funding.